Cargando…
Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD
Long-term, low-dose azithromycin reduces exacerbation frequency in chronic obstructive pulmonary disease (COPD), yet the mechanism remains unclear. This study characterised genome-wide gene expression changes in patients with neutrophilic COPD following long-term, low-dose azithromycin treatment. Pa...
Autores principales: | Baines, Katherine J., Wright, Thomas K., Gibson, Peter G., Powell, Heather, Hansbro, Philip M., Simpson, Jodie L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215914/ https://www.ncbi.nlm.nih.gov/pubmed/30406125 http://dx.doi.org/10.1183/23120541.00031-2018 |
Ejemplares similares
-
The Effect of Azithromycin in Adults with Stable Neutrophilic COPD: A Double Blind Randomised, Placebo Controlled Trial
por: Simpson, Jodie L., et al.
Publicado: (2014) -
Influence of Age, Past Smoking, and Disease Severity on TLR2, Neutrophilic Inflammation, and MMP-9 Levels in COPD
por: Simpson, Jodie L., et al.
Publicado: (2013) -
Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD
por: Negewo, Netsanet A, et al.
Publicado: (2016) -
Blood Neutrophils In COPD But Not Asthma Exhibit A Primed Phenotype With Downregulated CD62L Expression
por: Lokwani, Ravi, et al.
Publicado: (2019) -
Airway β-Defensin-1 Protein Is Elevated in COPD and Severe Asthma
por: Baines, Katherine J., et al.
Publicado: (2015)